Merck & Co. Inc. buy Barclays PLC
Start price
02.02.24
/
50%
€116.60
Target price
02.02.25
€134.11
Performance (%)
-18.18%
End price
03.02.25
€95.40
Summary
This prediction ended on 03.02.25 with a price of €95.40. The prediction for Merck & Co. Inc. disappointed with a performance of -18.18%. A total of €2.89 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 1.777% | 1.777% | -9.484% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Barclays PLC from $135.00 to $145.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€98.90
07.10.24
07.10.24
€127.58
07.10.25
07.10.25
-23.46%
08.10.25
08.10.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.14
31.07.25
31.07.25
-34.80%
01.08.25
01.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€108.20
23.01.24
23.01.24
€124.16
23.01.25
23.01.25
-14.23%
24.01.25
24.01.25